Steroids
The administration of steroids for the purpose of reducing or
limiting the formation of edema is another time-honored practice in neurosurgery.
The efficacy of steroids in reducing the edema associated with tumors is well confirmed.
[49]
[50]
[51]
The time course of this effect is relatively rapid, though not so rapid that it
is relevant to the management of intraoperative events. However, administration
beginning 48 hours before an elective surgical procedure has the potential to reduce
edema formation and improve the clinical condition by the time of craniotomy.[49]
[50]
[52]
Although
clinical improvement, specifically, a decreased frequency of ICP plateau waves and
an improvement in the pressure-volume response (the increment in ICP in response
to a standardized intracranial volume challenge), occurs within 24 hours,[49]
a reduction in ICP may not occur for 48 to 72 hours after the initiation of therapy.
[49]
This has been interpreted to indicate that
steroids in some way improve the "viscoelastic properties" of the intracranial space
before a reduction in edema occurs, although the mechanism is undefined.[52]
Steroids are usually given intraoperatively and postoperatively to maintain the
effects achieved by preoperative treatment.
The practice of administering steroids to adult head injury patients
has largely been abandoned as a result of controlled trials that demonstrated either
no benefit or deleterious effects.[53]
[54]
[55]
No such studies have been performed
in pediatric trauma victims, and practices vary among pediatric neurosurgeons with
respect to the administration of steroids after head injury in this population.
A recent European trial reported a benefit of the administration of large doses of
triamcinolone in adult head injury victims with focal intracranial lesions.[56]
The potent fluorinated steroids had not been studied previously in this population.
The results of this study have prompted a reconsideration of the use of steroids
in head-injured patients, and a trial of high-dose methylprednisolone is under way.